Document is current
Any future updates will be listed below
-
Authors
Acosta-Medina, Aldo A. https://orcid.org/0000-0001-9414-9153
Abeykoon, Jithma P. https://orcid.org/0000-0003-3939-6252
Zanwar, Saurabh https://orcid.org/0000-0001-5074-8453
Ruan, Gordon J. https://orcid.org/0000-0002-6969-9169
Rech, Karen L. https://orcid.org/0000-0001-6770-2339
Ravindran, Aishwarya https://orcid.org/0000-0003-4503-440X
Bennani, N. Nora
Davidge-Pitts, Caroline J.
Koster, Matthew J.
Ryu, Jay H. https://orcid.org/0000-0002-9576-2272
Shah, Mithun V. https://orcid.org/0000-0002-5359-336X
Tobin, W. Oliver https://orcid.org/0000-0002-8141-2394
Vassallo, Robert https://orcid.org/0000-0003-2328-0255
Young, Jason R. https://orcid.org/0000-0001-5351-8266
Go, Ronald S. https://orcid.org/0000-0002-8284-3495
Goyal, Gaurav https://orcid.org/0000-0001-6148-5177
,
- License Information
-
More Information
Article History
Received: 26 October 2024
Revised: 2 January 2025
Accepted: 28 January 2025
First Online: 11 February 2025
Competing interests
: GG has served on advisory boards of Opna Bio and Seagen and receives consultancy fees from Recordati; MJK has served in the advisory board of Amgen and has received writing services fees from Genentech; MVS has received research funding to the institution from AbbVie, Celgene, KURA Oncology, and MRKR Therapeutics; NNB has served in the advisory boards of Secure Bio, Affimed GmbH, Astellas Pharma, and Acrotech Biopharma LLC, in the Scientific Advisory committee of Acrotech Biopharma LLC, and in tumor board educational activities with OncoLense with no personal compensation for any of the advisory boards; RV has received funding from Pfizer, Bristol Myers Squibb and Sun Pharma, and has received consultancy fees from Sanofi.
: This study complies with all relevant ethical guidelines and regulations according to the Declaration of Helsinki and was approved by the Institutional Review Board of both institutions. All patients included had provided consent for participation in research studies.
